Novavax: Corona dead vaccine before EU approval on Monday

Federal Minister of Health Karl Lauterbach expects that the new corona vaccine from the US manufacturer Novavax will be approved by the EU drug authority EMA on Monday. That said the SPD politician on Sunday evening in the picture show “The Right Questions”. At the same time Lauterbach warned against the assumption that the new vaccine “will be a game changer”. According to studies, the vaccines from Moderna and Biontech, which have already been administered millions of times, are “a whole lot safer”.

The EMA, based in Amsterdam, will advise on the approval of the Novavax vaccine on Monday. According to the drug authority, the responsible commission of experts will then deal with the application for approval in an extraordinary meeting. The experts had evaluated studies on the effects and risks in the ongoing test procedure. If they recommend approval, the EU Commission still has to give its approval. But that is a matter of form.

Corona: So far, four vaccines have been approved in the EU

So far, four vaccines have been approved in the EU. The Novavax preparation could now possibly persuade some non-vaccinated people who have doubts about the principle of action of the other active ingredients to vaccinate. In contrast to the previously approved vaccines, the preparation is neither an mRNA vaccine – like the preparations from Biontech and Moderna – nor a vector vaccine like those from Astrazeneca and Johnson & Johnson. The vaccine contains tiny particles made up of a laboratory-made version of the Sars-CoV-2 spike protein.

Around every fourth person in Germany has not yet received a first vaccination against the coronavirus. However, this also includes younger children under the age of five who are not yet allowed to be vaccinated and older children who have only recently started vaccinations, as well as people who cannot be vaccinated for medical reasons.